ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 89 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,660 | +11.4% | 1,193,030 | 0.0% | 0.59% | +54.2% |
Q2 2023 | $12,264 | +33.2% | 1,193,030 | 0.0% | 0.38% | -30.5% |
Q1 2023 | $9,210 | +5.0% | 1,193,030 | 0.0% | 0.55% | +11.9% |
Q4 2022 | $8,769 | -99.9% | 1,193,030 | 0.0% | 0.49% | +33.2% |
Q3 2022 | $8,590,000 | +70.2% | 1,193,030 | +101.2% | 0.37% | +35.9% |
Q2 2022 | $5,047,000 | -5.1% | 593,030 | 0.0% | 0.27% | +21.1% |
Q1 2022 | $5,319,000 | -35.2% | 593,030 | 0.0% | 0.22% | 0.0% |
Q4 2021 | $8,213,000 | +29.8% | 593,030 | 0.0% | 0.22% | +57.0% |
Q3 2021 | $6,328,000 | +18.6% | 593,030 | 0.0% | 0.14% | +31.5% |
Q2 2021 | $5,337,000 | -15.1% | 593,030 | 0.0% | 0.11% | -2.7% |
Q1 2021 | $6,286,000 | -15.9% | 593,030 | 0.0% | 0.11% | -30.6% |
Q4 2020 | $7,472,000 | +43.3% | 593,030 | 0.0% | 0.16% | +26.0% |
Q3 2020 | $5,213,000 | – | 593,030 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,571,450 | $32,400,000 | 2.50% |
Omega Fund Management, LLC | 1,284,900 | $16,190,000 | 2.43% |
Avidity Partners Management LP | 1,248,000 | $15,725,000 | 0.51% |
Samsara BioCapital, LLC | 399,190 | $5,030,000 | 0.51% |
EcoR1 Capital, LLC | 741,290 | $9,340,000 | 0.50% |
DAFNA Capital Management LLC | 113,202 | $1,426,000 | 0.42% |
TIGER MANAGEMENT L.L.C. | 137,728 | $1,735,000 | 0.39% |
Orbimed Advisors | 3,070,955 | $38,694,000 | 0.34% |
SPHERA FUNDS MANAGEMENT LTD. | 198,260 | $2,498,000 | 0.22% |
Artal Group S.A. | 593,030 | $7,472,000 | 0.16% |